SAIC
Science Applications International Corporation NASDAQ Listed Sep 16, 2013$102.39
-4.07%
vs $106.73
Mkt Cap $4.8B
52w Low $82.22
52.6% of range
52w High $120.60
50d MA $100.42
200d MA $98.31
P/E (TTM)
13.3x
EV/EBITDA
10.6x
P/B
3.2x
Debt/Equity
1.8x
ROE
22.3%
P/FCF
8.3x
RSI (14)
47.30
ATR (14)
$4.85
Beta
0.30
50d MA
$100.42
200d MA
$98.31
Avg Volume
608.1K
Science Applications International Corporation provides technical, engineering, and enterprise information technology (IT) services primarily in the United States. The company's offerings include engineering; technology integration; IT modernization; maintenance of ground and maritime systems; logistics; training and simulation; operation and program support services; and end-to-end services, such as design, development, integration, deployment, management and operations, sustainment, and security of its customers' IT infrastructure, as well as cloud migration, managed services, infrastructure modernization, and enterprise IT-as-a-service solutions. It serves the U.S. military comprising Army, Air Force, Navy, Marines, and Coast Guard; Department of Defense agencies; National Aeronautics and Space Administration; the U.S. Department of State; Department of Justice; Department of Homeland Security; and various intelligence community agencies, as well as U.S. federal civilian agencies. The company was formerly known as SAIC Gemini, Inc. and changed its name to Science Applications International Corporation in September 2013. Science Applications International Corporation was founded in 1969 and is headquartered in Reston, Virginia.
12010 Sunset Hills Road · Reston, VA 20190 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | AMC | 2.26 | 3.23 | +42.9% | 115.08 | -1.4% | -1.5% | +1.2% | +1.6% | -1.9% | -1.0% | — |
| Mar 16, 2026 | AMC | 2.31 | 2.62 | +13.4% | 93.05 | +0.7% | +1.6% | +1.9% | +0.8% | -0.4% | +0.1% | — |
| Dec 4, 2025 | AMC | 2.07 | 2.58 | +24.6% | 101.79 | -1.4% | -1.2% | -1.7% | -1.6% | +3.4% | -0.7% | — |
| Sep 4, 2025 | AMC | — | 2.71 | — | 106.22 | +0.5% | -1.2% | -2.2% | +0.2% | +0.3% | +3.2% | — |
| Jun 2, 2025 | AMC | 2.14 | 1.92 | -10.3% | 100.22 | +1.1% | +3.2% | -1.1% | +0.2% | +2.8% | -1.7% | — |
| Mar 17, 2025 | AMC | 2.00 | 2.57 | +28.5% | 111.90 | -0.6% | +1.4% | -0.6% | -6.0% | -0.1% | +3.1% | — |
| Dec 5, 2024 | AMC | 2.17 | 2.61 | +20.3% | 120.78 | +0.4% | -2.3% | -1.7% | -0.1% | -2.1% | +0.0% | — |
| Sep 5, 2024 | AMC | 1.86 | 2.05 | +10.2% | 135.28 | -0.3% | -1.6% | +1.1% | +0.3% | -0.7% | +0.7% | — |
| Jun 3, 2024 | AMC | 1.92 | 1.92 | +0.0% | 118.81 | -2.5% | -1.3% | +0.7% | -1.1% | -0.9% | -0.1% | — |
| Mar 18, 2024 | AMC | 1.44 | 1.43 | -0.7% | 128.40 | +0.2% | -1.3% | +0.2% | +0.6% | -1.0% | +0.6% | — |
| Dec 4, 2023 | AMC | 1.69 | 2.27 | +34.3% | 136.00 | -0.8% | -3.1% | -1.6% | -0.5% | -1.0% | +0.3% | — |
| Sep 7, 2023 | AMC | 1.60 | 2.05 | +28.1% | 109.91 | +0.4% | +0.4% | +0.1% | +0.8% | +0.0% | -0.1% | — |
| Jun 5, 2023 | AMC | 1.82 | 2.14 | +17.6% | 102.65 | -1.0% | +0.5% | +0.6% | +1.2% | +0.6% | +1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 | BNP Paribas Exane | Initiates | Neutral | $95 | $101.36 | $100.83 | -0.5% | +0.3% | +2.0% | +0.5% | +10.4% | -1.5% |
| Apr 13 | JP Morgan | Maintains | Neutral → Neutral | — | $91.72 | $91.99 | +0.3% | +3.6% | -0.6% | +1.8% | -1.0% | +0.2% |
| Apr 2 | Citigroup | Maintains | Buy → Buy | — | $97.32 | $97.32 | +0.0% | +2.9% | -0.5% | +1.3% | -2.9% | -3.0% |
| Mar 17 | Stifel | Maintains | Buy → Buy | — | $93.05 | $93.71 | +0.7% | +1.6% | +1.9% | +0.8% | -0.4% | +0.1% |
| Mar 17 | Truist | Maintains | Hold → Hold | — | $93.05 | $93.71 | +0.7% | +1.6% | +1.9% | +0.8% | -0.4% | +0.1% |
| Feb 12 | Goldman Sachs | Maintains | Sell → Sell | — | $82.22 | $82.23 | +0.0% | +1.5% | +3.8% | -1.7% | +4.0% | +2.8% |
| Jan 13 | Citigroup | Maintains | Buy → Buy | — | $114.32 | $114.66 | +0.3% | -1.4% | -4.2% | +2.4% | +0.4% | -2.6% |
| Dec 8 | UBS | Maintains | Neutral → Neutral | — | $100.61 | $101.82 | +1.2% | -1.7% | -1.6% | +3.4% | -0.7% | +0.2% |
| Dec 5 | JP Morgan | Maintains | Neutral → Neutral | — | $101.79 | $100.32 | -1.4% | -1.2% | -1.7% | -1.6% | +3.4% | -0.7% |
| Sep 10 | Jefferies | Maintains | Hold → Hold | — | $102.78 | $102.81 | +0.0% | +0.3% | +3.2% | +0.0% | -2.3% | -0.8% |
| Sep 8 | JP Morgan | Downgrade | Overweight → Neutral | — | $104.93 | $103.86 | -1.0% | -2.2% | +0.2% | +0.3% | +3.2% | +0.0% |
| Sep 8 | Goldman Sachs | Maintains | Sell → Sell | — | $104.93 | $103.86 | -1.0% | -2.2% | +0.2% | +0.3% | +3.2% | +0.0% |
| Sep 5 | Stifel | Maintains | Buy → Buy | — | $106.22 | $106.72 | +0.5% | -1.2% | -2.2% | +0.2% | +0.3% | +3.2% |
| Sep 5 | UBS | Maintains | Neutral → Neutral | — | $106.22 | $106.72 | +0.5% | -1.2% | -2.2% | +0.2% | +0.3% | +3.2% |
| Jul 24 | Truist | Maintains | Hold → Hold | — | $116.06 | $115.97 | -0.1% | -0.9% | -0.2% | -1.4% | +0.4% | -1.2% |
| Jun 9 | Barclays | Maintains | Equal Weight → Equal Weight | — | $105.32 | $105.34 | +0.0% | -1.7% | +0.1% | +0.2% | +1.1% | +0.5% |
| Jun 4 | Wells Fargo | Maintains | Overweight → Overweight | — | $103.43 | $103.72 | +0.3% | -1.1% | +0.2% | +2.8% | -1.7% | +0.1% |
| Jun 3 | Truist | Maintains | Hold → Hold | — | $100.22 | $101.37 | +1.1% | +3.2% | -1.1% | +0.2% | +2.8% | -1.7% |
| Jun 3 | UBS | Maintains | Neutral → Neutral | — | $100.22 | $101.37 | +1.1% | +3.2% | -1.1% | +0.2% | +2.8% | -1.7% |
| Jun 2 | Jefferies | Maintains | Hold → Hold | — | $115.54 | $105.21 | -8.9% | -13.3% | +3.2% | -1.1% | +0.2% | +2.8% |
| May 15 | Jefferies | Maintains | Hold → Hold | — | $118.95 | $119.55 | +0.5% | +2.5% | +1.2% | -0.6% | +0.4% | -0.6% |
| Apr 15 | JP Morgan | Maintains | Overweight → Overweight | — | $117.55 | $117.90 | +0.3% | -0.3% | -0.7% | +0.3% | -0.2% | +1.9% |
| Apr 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $109.08 | $110.42 | +1.2% | -0.1% | +3.6% | +0.0% | +3.2% | +0.9% |
| Mar 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $111.90 | $111.25 | -0.6% | +1.4% | -0.6% | -6.0% | -0.1% | +3.1% |
| Mar 18 | Truist | Maintains | Hold → Hold | — | $111.90 | $111.25 | -0.6% | +1.4% | -0.6% | -6.0% | -0.1% | +3.1% |
| Mar 18 | UBS | Maintains | Neutral → Neutral | — | $111.90 | $111.25 | -0.6% | +1.4% | -0.6% | -6.0% | -0.1% | +3.1% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $100.64 | $100.23 | -0.4% | +0.1% | -0.2% | -1.8% | -3.1% | +5.5% |
| Jan 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $113.95 | $112.86 | -1.0% | -0.2% | +2.1% | +1.8% | -1.4% | -0.5% |
| Jan 8 | TD Cowen | Downgrade | Buy → Hold | — | $113.95 | $112.86 | -1.0% | -0.2% | +2.1% | +1.8% | -1.4% | -0.5% |
| Dec 12 | Goldman Sachs | Maintains | Sell → Sell | — | $113.47 | $113.54 | +0.1% | +0.0% | -0.4% | +1.4% | -0.2% | -2.9% |
| Dec 6 | JP Morgan | Maintains | Overweight → Overweight | — | $120.78 | $121.21 | +0.4% | -2.3% | -1.7% | -0.1% | -2.1% | +0.0% |
| Dec 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $123.91 | $132.50 | +6.9% | -2.5% | -2.3% | -1.7% | -0.1% | -2.1% |
| Nov 26 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $122.22 | $124.45 | +1.8% | +1.5% | -0.6% | +0.8% | +0.1% | -1.1% |
| Oct 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $142.74 | $142.77 | +0.0% | +1.2% | +1.1% | +0.2% | +0.6% | +0.3% |
| Oct 10 | Citigroup | Maintains | Buy → Buy | — | $143.35 | $143.19 | -0.1% | -0.4% | +1.2% | +1.1% | +0.2% | +0.6% |
| Oct 2 | JP Morgan | Upgrade | Neutral → Overweight | — | $140.77 | $143.14 | +1.7% | +1.8% | +0.5% | +1.1% | -1.1% | -0.6% |
| Sep 16 | Barclays | Maintains | Equal Weight → Equal Weight | — | $136.62 | $137.27 | +0.5% | +0.7% | -2.6% | +0.3% | +0.2% | +0.5% |
| Sep 6 | Citigroup | Maintains | Buy → Buy | — | $135.28 | $134.91 | -0.3% | -1.6% | +1.1% | +0.3% | -0.7% | +0.7% |
| Sep 6 | JP Morgan | Maintains | Neutral → Neutral | — | $135.28 | $134.91 | -0.3% | -1.6% | +1.1% | +0.3% | -0.7% | +0.7% |
| Sep 6 | TD Cowen | Maintains | Buy → Buy | — | $135.28 | $134.91 | -0.3% | -1.6% | +1.1% | +0.3% | -0.7% | +0.7% |
| Sep 6 | Truist | Maintains | Hold → Hold | — | $135.28 | $134.91 | -0.3% | -1.6% | +1.1% | +0.3% | -0.7% | +0.7% |
| Jul 10 | JP Morgan | Maintains | Neutral → Neutral | — | $113.40 | $113.57 | +0.1% | +0.5% | +2.1% | +1.2% | +0.5% | +3.9% |
| Jun 4 | Truist | Maintains | Hold → Hold | — | $118.81 | $115.83 | -2.5% | -1.3% | +0.7% | -1.1% | -0.9% | -0.1% |
| Apr 12 | Truist | Maintains | Hold → Hold | — | $126.36 | $125.64 | -0.6% | -2.2% | -2.0% | +2.4% | +0.5% | -1.2% |
| Mar 19 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $128.40 | $128.69 | +0.2% | -1.3% | +0.2% | +0.6% | -1.0% | +0.6% |
| Mar 19 | JP Morgan | Maintains | Neutral → Neutral | — | $128.40 | $128.69 | +0.2% | -1.3% | +0.2% | +0.6% | -1.0% | +0.6% |
| Feb 29 | Goldman Sachs | Maintains | Sell → Sell | — | $140.01 | $140.06 | +0.0% | -0.0% | +0.6% | +1.5% | +0.1% | +0.1% |
| Dec 5 | Truist | Maintains | Hold → Hold | — | $136.00 | $134.90 | -0.8% | -3.1% | -1.6% | -0.5% | -1.0% | +0.3% |
| Dec 5 | JP Morgan | Downgrade | Overweight → Neutral | — | $136.00 | $134.90 | -0.8% | -3.1% | -1.6% | -0.5% | -1.0% | +0.3% |
| Dec 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $136.00 | $134.90 | -0.8% | -3.1% | -1.6% | -0.5% | -1.0% | +0.3% |
No insider trades available.
8-K
Science Applications International Corporation -- 8-K Filing
I cannot provide a meaningful analysis because the filing summary contains only metadata and technical formatting information without substantive business details or announced transactions.
Jun 8
8-K
Science Applications International Corporation -- 8-K Filing
This is an incomplete 8-K filing excerpt that doesn't contain sufficient information about a material event to assess investor impact.
Jun 1
8-K
Science Applications International Corporation -- 8-K Filing
SAIC filed an 8-K disclosing its status as an emerging growth company under SEC Exchange Act regulations, affecting reporting requirements and exemptions available to the corporation.
Jun 1
8-K
Science Applications International Corporation -- 8-K Filing
May 29
8-K
Unknown — 8-K Filing
A seasoned technology executive with Google and Airbus leadership experience has joined the company, likely signaling strategic focus on innovation and advanced projects that could drive competitive advantage and revenue growth.
Apr 9
8-K
Unknown — 8-K Filing
A defense contractor executive is joining an AI company focused on complex systems engineering, signaling potential integration of advanced AI into defense/aerospace applications and positioning the company for major enterprise contracts.
Apr 9
8-K
Unknown — 8-K Filing
This 8-K filing lacks substantive disclosures, suggesting either a minor procedural filing or potential missing material information that could affect SAIC's stock valuation and investor confidence.
Mar 16
8-K
Unknown — 8-K Filing
SAIC's discretionary dividend policy tied to earnings and capital needs signals management expects stable cash generation, but investors should monitor quarterly results closely since payouts aren't guaranteed.
Mar 13
8-K · 5.02
!!! Very High
Science Applications International Corporation -- 8-K 5.02: Executive Change
Science Applications International Corporation appointed James C. Reagan as CEO effective February 17, 2026, replacing the departing chief executive in a leadership transition at the defense contractor.
Feb 17
8-K · 7.01
! Medium
Science Applications International Corporation -- 8-K 7.01: Regulation FD Disclosure
Science Applications International Corporation cannot reliably forecast GAAP net income or operating cash flows due to unpredictable non-GAAP adjustment amounts, limiting investors' visibility into future financial performance.
Feb 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 2,377,637 | $226M | New | Mar 2026 |
| 2 | Aqr Capital Management Llc | 2,145,769 | $204M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 2,020,470 | $192M | New | Mar 2026 |
| 4 | First Trust Advisors Lp | 1,497,019 | $142M | Reduced | Mar 2026 |
| 5 | Invesco Ltd. | 1,486,359 | $141M | Added | Mar 2026 |
| 6 | Morgan Stanley | 1,115,878 | $112M | Added | Dec 2025 |
| 7 | Fmr Llc | 822,283 | $78M | Reduced | Mar 2026 |
| 8 | Boston Partners | 617,868 | $59M | Reduced | Mar 2026 |
| 9 | River Road Asset Management, Llc | 482,907 | $46M | Added | Mar 2026 |
| 10 | Bank Of New York Mellon Corp | 431,455 | $41M | Added | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 380,538 | $36M | Added | Mar 2026 |
| 12 | Ubs Group Ag | 368,037 | $35M | Added | Mar 2026 |
| 13 | Northern Trust Corp | 364,158 | $35M | — | Mar 2026 |
| 14 | Allspring Global Investments Holdings, Llc | 204,976 | $20M | Reduced | Mar 2026 |
| 15 | Woodline Partners Lp | 208,893 | $20M | Reduced | Mar 2026 |
| 16 | Systematic Financial Management Lp | 182,029 | $17M | Reduced | Mar 2026 |
| 17 | Barclays Plc | 176,156 | $17M | Reduced | Mar 2026 |
| 18 | Raymond James Financial Inc | 169,181 | $16M | Added | Mar 2026 |
| 19 | Connor, Clark & Lunn Investment Management Ltd. | 159,472 | $16M | Reduced | Dec 2025 |
| 20 | Citadel Advisors Llc | 161,163 | $15M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$4.76B
Enterprise Value
$7.05B
P/E (TTM)
13.30x
Forward P/E
10.63x
PEG Ratio
1.90x
P/B
3.16x
P/S
0.66x
P/FCF
8.25x
EV/EBITDA
10.61x
Shares Out
46.5M
Financials (TTM)
Revenue
$7.26B
Net Income
$358.0M
EBITDA
$664.0M
Free Cash Flow
$577.0M
Op Cash Flow
$609.0M
EPS Basic
$7.73
EPS Diluted
$7.70
EPS Forward
$9.63
Gross Margin
12.0%
Op Margin
7.1%
Net Margin
4.9%
Balance Sheet
Total Assets
$5.35B
Total Liab.
$3.85B
Total Equity
$1.50B
Cash
$182.0M
LT Debt
$2.47B
Book Value/Sh
$32.40
Debt/Equity
1.80x
Current Ratio
1.20
Quick Ratio
1.20
Returns & Growth
ROE
22.3%
ROA
6.2%
ROIC
10.8%
Rev Growth YoY
-2.9%
EPS Growth YoY
+6.9%
Price Returns
2W
+12.5%
1M
+7.7%
3M
+12.9%
6M
+20.9%
12M
-9.8%
Technicals
52W High
$120.60
52W Low
$82.22
50d MA
$100.42
200d MA
$98.31
RSI (14)
47.30
ATR (14)
$4.85
Beta
0.30
Avg Volume
608K
Dividends
Div Rate
$1.51
Div Yield
1.6%
Frequency
4
Ex-Div Date
Apr 10, 2026
Analyst Price Targets
Consensus
$97.50
High
$113.00
Low
$82.00
Median
$97.50
Data updated apr 27, 2026 12:03am
· Source: financialmodelingprep.com